Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Melanoma: HELP
Articles by Walter Refkalefsky Loureiro
Based on 1 article published since 2010
(Why 1 article?)

Between 2010 and 2020, Walter Refkalefsky Loureiro wrote the following article about Melanoma.
+ Citations + Abstracts
1 Guideline Brazilian guidelines for diagnosis, treatment and follow-up of primary cutaneous melanoma - Part II. 2016

Castro, Luiz Guilherme Martins / Bakos, Renato Marchiori / Duprat Neto, João Pedreira / Bittencourt, Flávia Vasques / Di Giacomo, Thais Helena Bello / Serpa, Sérgio Schrader / Messina, Maria Cristina de Lorenzo / Loureiro, Walter Refkalefsky / Macarenco, Ricardo Silvestre e Silva / Stolf, Hamilton Ometto / Gontijo, Gabriel. ·Hospital Israelita Albert Einstein, SP, Brazil. · Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. · Departamento de Câncer de Pele, A. C. Camargo Cancer Center, São Paulo, SP, Brazil. · Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil. · Universidade Estácio de Sá, Rio de Janeiro, RJ, Brazil. · Universidade Estadual do Pará, Belém, PA, Brazil. · Universidade Estadual Paulista "Júlio de Mesquita Filho", Botucatu, SP, Brazil. ·An Bras Dermatol · Pubmed #26982779.

ABSTRACT: The last Brazilian guidelines on melanoma were published in 2002. Development in diagnosis and treatment made updating necessary. The coordinators elaborated ten clinical questions, based on PICO system. A Medline search, according to specific MeSH terms for each of the 10 questions was performed and articles selected were classified from A to D according to level of scientific evidence. Based on the results, recommendations were defined and classified according to scientific strength. The present Guidelines were divided in two parts for editorial and publication reasons. In this second part, the following clinical questions were answered: 1) which patients with primary cutaneous melanoma benefit from sentinel lymph node biopsy? 2) Follow-up with body mapping is indicated for which patients? 3) Is preventive excision of acral nevi beneficious to patients? 4) Is preventive excision of giant congenital nevi beneficious to patients? 5) How should stages 0 and I primary cutaneous melanoma patients be followed?